![]() |
![]() |
J Acupunct Res > Volume 38(1); 2021 > Article |
|
No. | First author (y), [ref] | Sample size | Intervention | Control | Treatment | Evaluation index | Result (A > B, C) | Adverse event | Acupoints | |
---|---|---|---|---|---|---|---|---|---|---|
No. | Period | |||||||||
01 | Le (2002) [13] | 116 | A: SMR+B (n = 56) | B: Atx (n = 60) | Unclear | Unclear | 1. Diagnostic criteria and efficacy of TCM diseases | 1. p < 0.05 | NR | EX18 |
02 | Zhou (2006) [14] | 94 | A: SMR+B (n = 48) | B: E-Atx +IR+Traction (n = 46) | 6× | 12 d | 1. Evaluation criteria for non-surgical treatment efficacy of HIVD | 1. p < 0.05 | NR | EX18, BL54, GB30, BL36, BL40, BL57, GB34 |
03 | Sun (2007) [15] | 90 | A: SMR +E-Atx (n = 30) |
B: Vitamin inj,+ E-Atx (n = 30) C: E-Atx (n = 30) |
20× | 25 d |
1 .JOA 2. VAS 3. NCV |
1. p < 0.05, 2. p < 0.05, 3. p > 0.05 (A, B), p < 0.05 |
NR | EX18 |
04 | Wang (2008) [16] | 130 | A: SMR (n = 65) | B: Atx (n = 65) | 7× | 10 d | 1. Diagnostic criteria and efficacy of TCM diseases | 1. p < 0.05 | NR | EX18 |
05 | Wang (2013) [17] | 86 | A: SMR+B (n = 42) | B: IR (n = 44) | 20× | 20 d | 1. JOA | 1. p < 0.05 | NR | GV3, GV4, BL25, BL17, ashi point, GB30, BL36, GB31, GB34, BL40, BL57, LR3, BL60 |
06 | Ye (2013) [18] | 80 | A: SMR+B (n = 40) | B: W-med +Traction (n = 40) | 3× | 15 d |
1. JOA 2. VAS |
1. p < 0.05, 2. p < 0.05 |
NR | EX18 |
07 | Xu (2015) [19] | 100 | A: SMR+B (n = 50) | B: W-med +Traction+Atx (n = 50) | Unclear | Unclear |
1. JOA 2. VAS |
1. p < 0.05 2. p < 0.05 |
NR | BL25, BL24 |
08 | Yang (2016) [20] | 90 | A: SMR (n = 45) | B: Atx (n = 45) | 12× | 4 wk |
1. VAS 2. ODI |
1. p < 0.05 2. p < 0.05 |
NR | BL23, BL25 |
09 | Wang (2017) [21] | 120 | A: SMR (n = 60) | B: W-med injection (n = 60) | 20× | 2 mo |
1. JOA 2. VAS 3. FMA 4. BI |
1. p < 0.05 2. p < 0.05 3. p < 0.05 4. p < 0.05 |
NR | BL23, GV4 |
10 | Zhang (2017) [22] | 80 | A: SMR+B (n = 40) | B: W-med +Traction (n = 40) | 15× | 15 d |
1. JOA 2. VAS |
1. p < 0.05 2. p < 0.05 |
NR | EX18 |
11 | Sun (2018) [23] | 180 | A: SMR+B (n = 90) | B: Atx+Traction (n = 90) | 14× | 14 d |
1. JOA 2. VAS |
1. p < 0.05 2. p < 0.05 |
NR | BL25, BL24 |
12 | Wang (2018) [24] | 136 | A: SMR+B (n = 68) | B: Atx+Traction (n = 68) | 14× | 14 d |
1. JOA 2. VAS |
1. p < 0.05 2. p < 0.05 |
NR | BL25, BL24 |
13 | He (2019) [25] | 66 | A: SMR+B (n = 33) | B: Atx (n = 33) | 8× | 24 d |
1. JOA 2. VAS |
1. p < 0.01 | NR | BL23, BL25, ashi point |
14 | Zhang (2019) [26] | 136 | A: SMR+B (n = 68) | B: HFTTR (n = 68) | 16× | 16 d |
1. JOA 2. VAS 3. ODI 4. Detecting mediators of serum inflammatory reactions |
1. p < 0.05 2. p < 0.05 3. p < 0.05 4. p < 0.05 |
NR | GV2, ST36 |
Atx, acupuncture treatment; BI, Barthel Index; E-Atx, electric acupuncture treatment; HIVD, herniated inter vertebral disc; FMA, Fugl-Meyer assessment; HFTTR, high-frequency thermocoagulation targeted resection; IR, infrared therapy; inj., injection; JOA, Japanese Orthopedic Association; n, sample size; NR, not reported; ODI, overseas development institute; RF-TCTR, radiofrequency thermal coagulation target resection; SMR, Salviae Miltiorrhizae radix; TCM, traditional chinese medicine; VAS, visual analogue scale; W-med, western medicine.
![]() |
![]() |